Quick Access

NPC1L1 Knockout A-549 Cell Line

NPC1L1 Knockout A-549 Cell Line

NPC1L1 Knockout Cell Line (A549) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.

Cat. No EDC08212
Species Human
Cell Line A-549
Gene NPC1L1
Size 1×10⁶ cells

Product Details

Cat.No. EDC08212 Product Name NPC1L1 Knockout A549 Cell Line
Cell Line A-549 Cellosaurus ID CVCL_0023
Cell Line Synonyms A 549, A549, NCI-A549, A549/ATCC, A549 ATCC, A549ATCC, hA549 Gene
NCBI Gene ID Gene Synonyms LDLCQ7|NPC11L1|SLC65A2
Summary
The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Associated Diseases Non-Small Cell Lung Carcinoma
Morphology Adherent Passage Ratio 1/5-1/4, 2days
Complete Culture Medium F-12K + 10% FBS Freezing Medium 95% Complete culture medium + 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.

STR Profile

LociSTR Info (Sample Cell)
Sample Cell Line: A-549
STR Info (Cell bank)
Cell Line: A-549
Allele1Allele2Allele1Allele2
Amelogenin X Y X Y
CSF1PO 10 12 10 12
D2S1338 24 24
D3S1358 16 16
D5S818 11 11
D7S820 8 11 8 11
D8S1179 13 14 13 14
D13S317 11 11
D16S539 11 12 11 12
D18S51 14 17 14 17
D19S433 13 13
D21S11 29 29
FGA 23 23
Penta D 9 9
Penta E 7 11 7 11
TH01 8 9.3 8 9.3
TPOX 8 11 8 11
vWA 14 14
D6S1043 11 13
D12S391 18 18
D2S441 10 13 10 13
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying NPC1L1's role as a cholesterol uptake transporter in a non-physiological cellular context (lung cancer cells do not endogenously express NPC1L1 at high levels — the principal sites are intestinal enterocytes and hepatic canalicular membrane). The Knockout line is appropriate when studying NPC1L1 in this non-physiological context — for example, as a clean genetic background for studying ezetimibe pharmacology in heterologous expression contexts. Overexpression studies of NPC1L1 in A-549 may be more informative than knockout given the limited endogenous NPC1L1 expression in lung cancer cells. Important consideration: A-549 is not a physiologically relevant context for NPC1L1 function. The EDITGENE NPC1L1 Knockout in A-549 is most useful for biochemistry, antibody specificity testing, or as a defined null background for heterologous NPC1L1 expression studies. For physiologically relevant NPC1L1 research, the parallel NPC1L1 Knockout in Huh-7 (also available, hepatocellular context) is the recommended product — Huh-7's hepatocellular origin matches NPC1L1's biliary canalicular expression context. Rescue with wild-type or transport-deficient NPC1L1 enables structure-function studies.
Yes, with the consideration that A-549 is not the physiological context: • Construct design: use a codon-modified NPC1L1 sequence with a small intracellular C-terminal tag (FLAG, HA). NPC1L1 has 13 transmembrane domains with a sterol-sensing domain (SSD) — preserve membrane topology. • Surface localization validation: confirm plasma membrane localization by cell surface staining; physiological apical/canalicular targeting may not occur in non-polarized A-549. • Transport-deficient rescue: SSD or sterol-binding pocket mutations abolish cholesterol uptake. • Functional readout: rescue should restore cellular cholesterol uptake and ezetimibe sensitivity, though baseline activities may be lower than in hepatocellular contexts. A-549 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
Contact Us
*
*
*
How did you hear about us: